Haiying Dong - Search Results

Year	Number of Results
2005	1
2006	1
2009	2
2010	2
2011	5
2012	4
2013	9
2014	6
2015	4
2016	1
2017	2
2018	4
2019	2
2020	2
2021	3
2022	6
2023	8
2024	10
2025	8
2026	9

1

Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway.

Ren S, Wang Y, Zhang Y, Yan P, Xiao D, Zhao Y, Jia W, Ding L, Dong H, Wei C, Lin S, Lin Y. Ren S, et al. Among authors: dong h. Biomed Pharmacother. 2023 Sep;165:115253. doi: 10.1016/j.biopha.2023.115253. Epub 2023 Aug 3. Biomed Pharmacother. 2023. PMID: 37542855 Free article.

2

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.

Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Free article. Clinical Trial.

3

Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Chen J, Hu X, Zhao J, Yin X, Zheng L, Guo J, Chen J, Wang Y, Sheng X, Dong H, Liu X, Zhang X, Liang J, Liu H, Yao J, Liu J, Shen Y, Chen Z, He Z, Wang Y, Chen N, Nie L, Zhang M, Pan X, Chen Y, Liu H, Zhang Y, Tang Y, Zhu S, Zhao J, Dai J, Wang Z, Zeng Y, Wang Z, Huang H, Liu Z, Shen P, Zeng H, Sun G. Chen J, et al. Among authors: dong h. Clin Cancer Res. 2024 Jun 3;30(11):2571-2581. doi: 10.1158/1078-0432.CCR-23-2760. Clin Cancer Res. 2024. PMID: 38512114 Free PMC article.

4

A randomized study of apalutamide in Chinese patients with non-metastatic castration-resistant prostate cancer.

Jiang S, Tian Y, Guo H, Guo J, Dong H, Luo H, Xue W, Xu T, Li L, Qiu M, Xie L, Lopez-Gitlitz A, McCarthy S, Liu Y, Ma H, Liang H, Li Y, Chen N, Ye D. Jiang S, et al. Among authors: dong h. iScience. 2025 Jul 18;28(8):113166. doi: 10.1016/j.isci.2025.113166. eCollection 2025 Aug 15. iScience. 2025. PMID: 40822333 Free PMC article.

5

Heat shock protein HSPA1A promotes porcine epidemic diarrhea virus replication by targeting the viral RNA-dependent RNA polymerase.

Tian H, Hao P, Dong H, Wu B, Liu H, Du H, Wang K, Du Q, Jia S, Zhang M, Caicike A, Zhao Y, Zhao G, Tong D, Huang Y. Tian H, et al. Among authors: dong h. Int J Biol Macromol. 2025 Nov;330(Pt 3):148267. doi: 10.1016/j.ijbiomac.2025.148267. Epub 2025 Oct 13. Int J Biol Macromol. 2025. PMID: 41093190

6

Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Cognetti DM, Curry JM, Johnson J, Kwon M, Su SY, Civantos F, Olazagasti C, Valentino J, Arnold SM, Bell RB, Gibson MK, Mannion K, Van Abel KM, Price KA, Dong H, Thorne AH, Suzuki T, Gillenwater AM. Cognetti DM, et al. Among authors: dong h. Head Neck. 2026 Jan;48(1):160-174. doi: 10.1002/hed.70014. Epub 2025 Aug 25. Head Neck. 2026. PMID: 40852760 Free PMC article. Clinical Trial.

7

Integrated bulk and single-cell transcriptomics to develop an efferocytosis-related prognostic model for lung adenocarcinoma and validate the key gene LDHA.

Zhang W, Chen Q, Li Y, Zhang L, Wang M, Sun B, Yang S, Yang F, Dong H. Zhang W, et al. Among authors: dong h. Eur J Med Res. 2025 Dec 4;31(1):49. doi: 10.1186/s40001-025-03622-z. Eur J Med Res. 2025. PMID: 41345972 Free PMC article.

8

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial.

Wu J, Li X, Gu C, Hua L, Liu R, Li J, Qiu M, Guo J, Dong H, Ji Z, Xie L, Zhu S, Zhang X, Chen P, Jiang S, Sun Z, Xu D, Chen H, Shi B, Wang Y, Pu J, Perabo F, Chen Y, Ye D. Wu J, et al. Among authors: dong h. Signal Transduct Target Ther. 2026 Apr 13;11(1):131. doi: 10.1038/s41392-026-02618-3. Signal Transduct Target Ther. 2026. PMID: 41968137 Free PMC article. Clinical Trial.

9

Multiple features of cell-free mtDNA for predicting transarterial chemoembolization response in hepatocellular carcinoma.

Dang M, Wang S, Peng F, Zhang R, Jiao H, Zhang H, Dong H, Zhang H, Xing J, Guo X, Liu Y. Dang M, et al. Among authors: dong h. Hepatol Commun. 2025 Feb 26;9(3):e0652. doi: 10.1097/HC9.0000000000000652. eCollection 2025 Mar 1. Hepatol Commun. 2025. PMID: 40008902 Free PMC article.

10

PRDM14 promoted NSCLC cell proliferation, migration and invasion via modulating H3K27me3-mediated PEBP1/Raf-1/MEK/ERK MAPK signaling.

Shi H, Jiang Y, Mu H, Liu G, Cheng X, Kong W, Zhou X, Wen X, Wang X, Lin Y, Pan L, Dong H, Bi H, He L, Zheng H, Shi H. Shi H, et al. Among authors: dong h. Genes Genomics. 2025 Oct;47(10):1027-1038. doi: 10.1007/s13258-025-01631-0. Epub 2025 Aug 26. Genes Genomics. 2025. PMID: 40856954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year